Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrroloquinolines for treatment of obesity

Pyrroloquinolines for treatment of obesity

US Patent 6365598 · Granted Apr 2, 2002

Estimated economic value: $68,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of SARM12025
Inhibitors of SARM12025
DNA polymerase theta inhibitor for treatment of cancer2024
Compounds, compositions, and therapeutic uses thereof2024
Phenyl amino piperidine mTORC inhibitors and uses thereof2020
Use of VAP-1 inhibitors for treating fibrotic conditions2020
Phenyl amino piperidine mTORC inhibitors and uses thereof2019
Fused imidazole and pyrazole derivatives as modulators of TNF activity2018
Use of VAP-1 inhibitors for treating fibrotic conditions2017
Substituted imidazo[1,2-a]pyrazines as TNF activity modulators2016
Therapeutic aryl-amido-aryl compounds and their use2016
Imidazopyridine derivatives as modulators of TNF activity2016